Literature DB >> 26252024

MicroRNA-144 affects radiotherapy sensitivity by promoting proliferation, migration and invasion of breast cancer cells.

Lei Yu1, Yanming Yang1, Jiguang Hou1, Chengwei Zhai1, Yunhao Song1, Zhiliang Zhang1, Ling Qiu1, Xiaojing Jia1.   

Abstract

Radiotherapy resistance remains a major obstacle for patients with breast cancer. miRNAs are important regulators in many biological processes including proliferation, apoptosis, invasion and metastasis and response to treatment in different types of tumors. Here, we describe the role of miRNA-144 in the regulation of radiotherapy sensitivity, migration and invasion of breast cancer cells. The cell survival rate of breast cancer cells was measured by WST-1 assay after irradiation. The caspase-3/-7 activity and apoptotic proteins were analyzed by Caspase-Glo3/7 assay and western blot analysis, respectively. The migration and invasion of breast cancer cells were evaluated by BD Transwell migration and Matrigel invasion assays. The EMT markers were detected by western blot analysis. We found that overexpression of miR-144 increased the proliferation rate of MDA-MB-231 cells without radiation. Both MDA-MB‑231 and SKBR3 cells exhibited significantly increased radiation resistance after overexpression of miR-144. Meanwhile, the migration and invasion of both MDA-MB-231 and SKBR3 cells were changed by altered miR-144 expression. In addition, the overexpression of miR-144 inhibited E-cadherin expression and promoted Snail expression. miR-144 activated AKT by downregulation of PTEN in breast cancer cells. Our results strongly suggest that miR-144 acts as an important regulator of tumorigenesis and tumor progression of breast cancer. These results indicate that miR-144 might serve as a potential molecular target for breast cancer treatment.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26252024     DOI: 10.3892/or.2015.4173

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  24 in total

Review 1.  Toward the promise of microRNAs - Enhancing reproducibility and rigor in microRNA research.

Authors:  Kenneth W Witwer; Marc K Halushka
Journal:  RNA Biol       Date:  2016-09-19       Impact factor: 4.652

2.  MiR-144 suppresses proliferation, invasion, and migration of breast cancer cells through inhibiting CEP55.

Authors:  Yuanqin Yin; Jingjing Cai; Fandong Meng; Chengguang Sui; Youhong Jiang
Journal:  Cancer Biol Ther       Date:  2018-03-26       Impact factor: 4.742

3.  MiR-144-3p inhibits cell proliferation and induces apoptosis in multiple myeloma by targeting c-Met.

Authors:  Yue Zhao; Zhongshi Xie; Jie Lin; Peng Liu
Journal:  Am J Transl Res       Date:  2017-05-15       Impact factor: 4.060

Review 4.  Radiation therapy for triple-negative breast cancer: emerging role of microRNAs as biomarkers and radiosensitivity modifiers. A systematic review.

Authors:  Nina Radosevic-Robin; Yazid Belkacemi; Nhu Hanh To; Hoang Quy Nguyen; Allan Thiolat; Bisheng Liu; José Cohen
Journal:  Breast Cancer Res Treat       Date:  2022-04-09       Impact factor: 4.872

Review 5.  Role of non-coding RNAs in response of breast cancer to radiation therapy.

Authors:  Nastaran Masoudi-Khoram; Parviz Abdolmaleki
Journal:  Mol Biol Rep       Date:  2022-02-25       Impact factor: 2.742

6.  MicroRNA analysis of breast ductal fluid in breast cancer patients.

Authors:  Luisa Matos Do Canto; Catalin Marian; Shawna Willey; Mary Sidawy; Patricia A Da Cunha; Janice D Rone; Xin Li; Yuriy Gusev; Bassem R Haddad
Journal:  Int J Oncol       Date:  2016-03-10       Impact factor: 5.650

7.  miR-144 functions as a tumor suppressor in breast cancer through inhibiting ZEB1/2-mediated epithelial mesenchymal transition process.

Authors:  Yuliang Pan; Jun Zhang; Huiqun Fu; Liangfang Shen
Journal:  Onco Targets Ther       Date:  2016-10-11       Impact factor: 4.147

8.  Mechanisms of Drug Resistance and Use of Nanoparticle Delivery to Overcome Resistance in Breast Cancers.

Authors:  Huseyin Beyaz; Hasan Uludag; Doga Kavaz; Nahit Rizaner
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

9.  MicroRNA-144 inhibits proliferation by targeting WW domain-containing transcription regulator protein 1 in papillary thyroid cancer.

Authors:  Wei Sun; Xiabin Lan; Zhihong Wang; Wenwu Dong; Liang He; Ting Zhang; Ping Zhang; Hao Zhang
Journal:  Oncol Lett       Date:  2017-11-17       Impact factor: 2.967

10.  miR-22 suppresses tumorigenesis and improves radiosensitivity of breast cancer cells by targeting Sirt1.

Authors:  Xia Zhang; Yuehua Li; Dan Wang; Xiaoer Wei
Journal:  Biol Res       Date:  2017-09-07       Impact factor: 5.612

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.